CUSIP 48576U205COM NEWKPTIQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
69 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Opaleye Management Inc. | 930.0K | $6.84M | +930.0K | New |
| 2 | Affinity Asset Advisors, LLC | 889.6K | $6.55M | +889.6K | New |
| 3 | Vanguard Group Inc | 559.6K | $4.12M | +151.4K | Added |
| 4 | Ikarian Capital, LLC | 544.6K | $4.01M |
| Added |
| 5 | Soleus Capital Management, L.P. | 440.0K | $3.24M | +440.0K | New |
| 6 | Adage Capital Partners Gp, L.L.C. | 421.3K | $3.10M | 0 | Held |
| 7 | Davidson Kempner Capital Management LP | 310.0K | $2.28M | +310.0K | New |
| 8 | Braidwell LP | 303.4K | $2.23M | +303.4K | New |
| 9 | Exome Asset Management LLC | 295.5K | $2.18M | +295.5K | New |
| 10 | Ameriprise Financial Inc | 276.9K | $2.04M | +276.9K | New |
See every fund holding Karyopharm Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders